FDA Finalizes Guidance on Patient-Focused Drug Development

By PacConAdmin | February 25, 2022

The FDA outlined its latest thinking on patient-focused drug development in a final guidance released on Friday, including ways to gather information that can be used for trial design.
Source: Drug Industry Daily

Posted in Drug Industry Daily